1211531-67-7

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-3-chloro-2-isopropoxypyridine serves as a crucial intermediate in the organic synthesis of various pharmaceutical compounds. Its unique structure, which includes bromine, chlorine, and isopropoxy groups, allows for the development of new drugs with potential therapeutic applications. As an intermediate, it plays a significant role in the synthesis of complex organic molecules, contributing to the advancement of medicinal chemistry.

Upstream product

• 282723-22-2 2-Isopropoxy-3-chloropyridine 
• 2402-77-9 2,3-dichloro-pyridine 
• 97966-00-2 5-bromo-2,3-dichloropyridine 
• 67-63-0 isopropyl alcohol 

Downstream Products

• 1355066-41-9 5-chloro-6-(1-propan-2-yloxy)-3-pyridinol 
• 1344997-98-3 ethyl 1-{2-[3-(5-{5-chloro-6-[(1-methylethyl)oxy]-3-pyridinyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]ethyl}-4-piperidinecarboxylate 
• 1344997-97-2 [3-(5-{5-chloro-6-[(1-methylethyl)oxy]-3-pyridinyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]acetaldehyde 
• 1344997-96-1 3-chloro-5-(3-{2-ethyl-3-[(E)-2-(methyloxy)ethenyl]phenyl}-1,2,4-thiadiazol-5-yl)-2-[(1-methylethyl)oxy]pyridine 

Relevant academic research and scientific papers

Cycloalkyl-substituted mesyl benzamide derivatives, and preparation method and medical application thereof

The invention relates to cycloalkyl-substitutedmesyl benzamide derivatives, and a preparation method and medical application thereof. The invention particularly discloses compounds disclosed as Formula (I) or pharmaceutically acceptable salts, stereoisomers, solvated compounds or prodrugs thereof, and a preparation method and application thereof. All the groups in the formula are defined in the specification.

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

The invention provides compounds having the general formula I, and pharmaceutically acceptable salts thereof, wherein the variables RA, RAA, subscript n, ring A, X2, L, subscript m, X1, R1, R2, R3, R4, R5, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

COMPOUNDS AS AGONISTS OF S1P1 RECEPTORS

Compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases mediated by S1P1 receptors.